Cancer Vaccines Market, Pipeline Analysis Report 2020


a??Global Cancer Vaccines market size is expected to surpass US$ 8.5 Billion by 2025a??

Report Scope:
a?? Detailed Insights of the Introduction to Cancer Vaccines and Mechanism of Cancer Vaccines
a?? The Market Size of the Global Cancer Vaccines Market with Five Years Forecast
a?? The Market Size of the 4 Leading Cancer Vaccines with Five Years Forecast
a?? Provides Comprehensive Insights on the Funding of the Cancer Vaccines Research
a?? Investigates the Key Growth Drivers and Restraints of the Global Cancer Vaccines Market
a?? Provides Key Trends with Respect to Collaboration Deals, Merger & Acquisitions, Partnership Deals, and Licensing Agreement
a?? Detailed Insights of the Regulatory Framework Including the Approval Process and an Overview of the Regulatory Authorities in the United States, EU, and Japan
a?? A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development
a?? An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development

a??Cancer Vaccines Market, Pipeline Analysis Report, 2020a?? provides a comprehensive analysis of the fast-evolving, high-growth global cancer vaccines market. The report offers the foremost up-to-date industry data on the specific market situation and future outlook for the global cancer vaccines market. The report provides historical market data for 2015 a?? 2019, and forecasts from 2020 till 2025.

The report contains a granular evaluation of the prevailing enterprise conditions, market demands, reveal facts in the marketplace, revenues, and offers forecasts through 2025. The report presents clear perception into current and future developments of the global cancer vaccines market. 

The report explores detailed insights into the introduction to cancer vaccines and the mechanism of cancer vaccines. The report additionally provides a detailed evaluation of the leading 4 key marketed cancer vaccines market assessments globally, data from 2015 to 2019, and forecasts to 2025. The report reviews a clear insight into the funding of the cancer vaccines studies. The report additionally investigates special insights about the regulatory landscape which include the approval system and an overview of the regulatory authorities in the United States, EU, and Japan.

Key developments of collaboration, partnerships, merger & acquisition, and licensing settlement are analyzed with details. The report additionally examines the principle marketplace growth drivers and restraining forces and also offers an all-round future outlook.

The report concludes with the profiles of the key players in the global cancer vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, vaccines revenue analysis, and recent development.

Other emerging players are making novel era-based vaccines that are in all possibility to have an effect on the market share during the forecast duration. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with the current stage of clinical evaluation, vaccines target, platform technology, and recent developments.

The following 4 leading vaccines of the global cancer vaccines market are detailed with market size and five-year forecast:
a?? Gardasil/Gardasil 9
a?? Cervarix
a?? Provenge
a?? Imlygic

The foremost companies dominating this market for its products, offerings, and non-stop product trends are:
a?? Amgen
a?? Merck & Co., Inc
a?? GlaxoSmithKline (GSK)
a?? Dendreon Pharmaceuticals (Sanpower Group)
a?? GeoVax,Inc
a?? Moderna, Inc
a?? Flow Pharma, Inc
a?? Polynoma LLC
a?? IO Biotech
a?? OncoPep, Inc
a?? Medigen, Inc
a?? ViciniVax
a?? ImmuneTune
a?? Treos Bio Limited
a?? EpiThany
a?? CureVac AG
a?? DCprime
a?? Vaximm AG
a?? AdaptVac
a?? MimiVax LLC
a?? Agenus, Inc
a?? AlphaVax, Inc
a?? Genexine
a?? GlobeImmune, Inc
a?? Ubivac, Inc
a?? Vaccinogen, Inc
a?? Genocea Biosciences, Inc
a?? Northwest Biotherapeutics, Inc
a?? OncBioMune Pharmaceuticals, Inc
a?? Inovio Pharmaceuticals, Inc
a?? Enochian Biosciences
a?? Eu Biologics Co., Ltd.
a?? EVOQ Therapeutics
a?? Heat Biologics, Inc
a?? Scancell Holdings PLC
a?? Anixa Biosciences, Inc
a?? PDC*line Pharma
a?? Elios Therapeutics, LLC
a?? OSE Immunotherapeutics

The Report Helps Solution the Following Questions:
a?? What is the current size of the overall global cancer vaccines market? How much will this market be worth from 2020 to 2025?
a?? What are the key marketed cancer vaccines? What are their revenue potentials to 2025?
a?? What are the main drivers and restraints in the global cancer vaccines market?
a?? What are the major deals happenings in the global cancer vaccines market?
a?? Who are the top market players and what are their happenings, vaccines revenue, current developments, and scenarios?
a?? What are some of the most prominent cancer vaccines currently in clinical development? What are their happenings, platform technology, and current developments?
1. Executive Summary

2. Introduction to Cancer Vaccines

3. Mechanism of Cancer Vaccines

4. Global Cancer Vaccines Market Size and Forecast (2015 a?? 2025)

5. Key Marketed Cancer Vaccines Market Value (2015 a?? 2025)
5.1 Gardasil/Gardasil 9
5.2 Cervarix
5.3 Provenge
5.4 Imlygic

6. Key Market Drivers and Inhibitors of the Cancer Vaccines Market
6.1 Key Market Drivers
6.2 Key Market Inhibitors

7. Funding in the Cancer Vaccines Research

8. Major Deals and Agreement Happenings in the Cancer Vaccines Market
8.1 Collaboration Deals
8.2 Licensing Agreement
8.3 Partnership Deals
8.4 Merger & Acquisitions

9. Regulatory Environment a?? Cancer Vaccines Approval Process
9.1 United States
9.2 Europe
9.3 Japan

10. Key Players Analysis
10.1 Merck & Co., Inc.
10.1.1 Business Overview
10.1.2 Vaccines Portfolio
10.1.3 Recent Development
10.2 GlaxoSmithKline (GSK)
10.2.1 Business Overview
10.2.2 Vaccines Portfolio
10.3 Dendreon Pharmaceuticals (Sanpower Group)
10.3.1 Business Overview
10.3.2 Vaccines Portfolio
10.3.3 Recent Development
10.4 Amgen
10.4.1 Business Overview
10.4.2 Vaccines Portfolio
10.4.3 Recent Development

11. Emerging Players Analysis
11.1 Genocea Biosciences,Inc
11.1.1 Business Overview
11.1.2 Promising Cancer Vaccines in the Clinical Development
11.1.3 Recent Development
11.2 GeoVax, Inc
11.2.1 Business Overview
11.2.2 Promising Cancer Vaccines in the Clinical Development
11.2.3 Recent Development
11.3 Moderna, Inc
11.3.1 Business Overview
11.3.2 Promising Cancer Vaccines in the Clinical Development
11.3.3 Recent Development
11.4 Northwest Biotherapeutics, Inc
11.4.1 Business Overview
11.4.2 Promising Vaccines in the Clinical Development
11.4.3 Recent Development
11.5 OncBioMune Pharmaceuticals, Inc
11.5.1 Business Overview
11.5.2 Promising Vaccines in the Clinical Development
11.5.3 Recent Development
11.6 Inovio Pharmaceuticals, Inc
11.6.1 Business Overview
11.6.2 Promising Cancer Vaccines in the Clinical Development
11.6.3 Recent Development
11.7 Enochian Biosciences
11.7.1 Business Overview
11.7.2 Promising Cancer Vaccines in the Clinical Development
11.8 Flow Pharma, Inc
11.8.1 Business Overview
11.8.2 Promising Cancer Vaccines in the Clinical Development
11.8.3 Recent Development
11.9 Polynoma LLC
11.9.1 Business Overview
11.9.2 Promising Cancer Vaccines in the Clinical Development
11.9.3 Recent Development
11.10 IO Biotech
11.10.1 Business Overview
11.10.2 Promising Cancer Vaccines in the Clinical Development
11.10.3 Recent Development
11.11 Eu Biologics Co., Ltd.
11.11.1 Business Overview
11.11.2 Promising Cancer Vaccines in the Clinical Development
11.12 OncoPep, Inc
11.12.1 Business Overview
11.12.2 Promising Cancer Vaccines in the Clinical Development
11.12.3 Recent Development
11.13 Medigen, Inc
11.13.1 Business Overview
11.13.2 Promising Cancer Vaccines in the Clinical Development
11.14 EVOQ Therapeutics
11.14.1 Business Overview
11.14.2 Promising Cancer Vaccines in the Clinical Development
11.15 Heat Biologics, Inc
11.15.1 Business Overview
11.15.2 Promising Cancer Vaccines in the Clinical Development
11.15.3 Recent Development
11.16 ViciniVax
11.16.1 Business Overview
11.16.2 Promising Cancer Vaccines in the Clinical Development
11.17 ImmuneTune
11.17.1 Business Overview
11.17.2 Promising Cancer Vaccines in the Clinical Development
11.18 Elios Therapeutics LLC
11.18.1 Business Overview
11.18.2 Promising Cancer Vaccines in the Clinical Development
11.18.3 Recent Development
11.19 Treos Bio Limited
11.19.1 Business Overview
11.19.2 Promising Cancer Vaccines in the Clinical Development
11.19.3 Recent Development
11.20 Scancell Holdings PLC
11.20.1 Business Overview
11.20.2 Promising Cancer Vaccines in the Clinical Development
11.20.3 Recent Development
11.21 EpiThany
11.21.1 Business Overview
11.21.2 Promising Cancer Vaccines in the Clinical Development
11.21.3 Recent Development
11.22 CureVac AG
11.22.1 Business Overview
11.22.2 Promising Cancer Vaccines in the Clinical Development
11.22.3 Recent Development
11.23 DCprime
11.23.1 Business Overview
11.23.2 Promising Cancer Vaccines in the Clinical Development
11.23.3 Recent Development
11.24 Vaximm AG
11.24.1 Business Overview
11.24.2 Promising Cancer Vaccines in the Clinical Development
11.24.3 Recent Development
11.25 Anixa Biosciences, Inc
11.25.1 Business Overview
11.25.2 Promising Cancer Vaccines in the Clinical Development
11.25.3 Recent Development
11.26 AdaptVac
11.26.1 Business Overview
11.26.2 Promising Cancer Vaccines in the Clinical Development
11.26.3 Recent Development
11.27 PDC*line Pharma
11.27.1 Business Overview
11.27.2 Promising Cancer Vaccines in the Clinical Development
11.27.3 Recent Development
11.28 MimiVax LLC
11.28.1 Business Overview
11.28.2 Promising Cancer Vaccines in the Clinical Development
11.28.3 Recent Development
11.29 Agenus, Inc
11.29.1 Business Overview
11.29.2 Promising Cancer Vaccines in the Clinical Development
11.30 AlphaVax, Inc
11.30.1 Business Overview
11.30.2 Promising Cancer Vaccines in the Clinical Development
11.31 Genexine
11.31.1 Business Overview
11.31.2 Promising Cancer Vaccines in the Clinical Development
11.31.3 Recent Development
11.32 GlobeImmune, Inc
11.32.1 Business Overview
11.32.2 Promising Cancer Vaccines in the Clinical Development
11.33 Ubivac, Inc
11.33.1 Business Overview
11.33.2 Promising Cancer Vaccines in the Clinical Development
11.34 Vaccinogen, Inc
11.34.1 Business Overview
11.34.2 Promising Cancer Vaccines in the Clinical Development
11.35 OSE Immunotherapeutics
11.35.1 Business Overview
11.35.2 Promising Cancer Vaccines in the Clinical Development
11.35.3 Recent Development

List of Tables: Table 8a??1: Collaboration Deals in the Cancer Vaccines Market Table 8a??2: Licensing Agreement in the Cancer Vaccines Market Table 8a??3: Partnership Deals in the Cancer Vaccines Market Table 8a??4: Merger & Acquisitions in the Cancer Vaccines Market Table 9a??1: United States a?? Simplified Regulatory Pathway from Preclinical to the Marketing Authorization Table 9a??2: European Union a?? Simplified Regulatory Pathway from Preclinical to the Marketing Authorization Table 9a??3: Japan a?? Simplified Regulatory Pathway from Preclinical to the Marketing Authorization Table 11a??1: Genocea Biosciences, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??2: GeoVax, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??3: Moderna, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??4: Northwest Biotherapeutics, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??5: OncBioMune Pharmaceuticals, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??6: Inovio Pharmaceuticals, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??7: Enochian Biosciences Promising Cancer Vaccines in the Clinical Development Table 11a??8: Flow Pharma, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??9: Polynoma LLC Promising Cancer Vaccines in the Clinical Development Table 11a??10: IO Biotech Promising Cancer Vaccines in the Clinical Development Table 11a??11: Eu Biologics Co., Ltd. Promising Cancer Vaccines in the Clinical Development Table 11a??12: OncoPep Promising Cancer Vaccines in the Clinical Development Table 11a??13: Medigen, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??14: EVOQ Therapeutics Promising Cancer Vaccines in the Clinical Development Table 11a??15: Heat Biologics, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??16: Vicinivax Promising Cancer Vaccines in the Clinical Development Table 11a??17: ImmuneTune Promising Cancer Vaccines in the Clinical Development Table 11a??18: Elios Therapeutics Promising Cancer Vaccines in the Clinical Development Table 11a??19: Treos Bio Limited Promising Cancer Vaccines in the Clinical Development Table 11a??20: Scancell Holdings PLC Promising Cancer Vaccines in the Clinical Development Table 11a??21: EpiThany Promising Cancer Vaccines in the Clinical Development Table 11a??22: CureVac AG Promising Cancer Vaccines in the Clinical Development Table 11a??23: DCprime Promising Cancer Vaccines in the Clinical Development Table 11a??24: Vaximm AG Promising Cancer Vaccines in the Clinical Development Table 11a??25: Anixa Biosciences, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??26: AdaptVac Promising Cancer Vaccines in the Clinical Development Table 11a??27: PDC*line Pharma Promising Cancer Vaccines in the Clinical Development Table 11a??28: MimiVax LLC Promising Cancer Vaccines in the Clinical Development Table 11a??29: Agenus, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??30: AlphaVax Promising Cancer Vaccines in the Clinical Development Table 11a??31: Genexine Promising Cancer Vaccines in the Clinical Development Table 11a??32: GlobeImmune, Inc Promising Cancer Vaccines in the Clinical Development Table 11a??33: Ubivac Promising Cancer Vaccines in the Clinical Development Table 11a??34: Vaccinogen Promising Cancer Vaccines in the Clinical Development Table 11a??35: OSE Immunotherapeutics Promising Cancer Vaccines in the Clinical Development List of Figures: Figure 4a??1: Global Cancer Vaccines Market Size (Million US$), 2015 a?? 2019 Figure 4a??2: Global Cancer Vaccines Market Forecast (Million US$), 2020 a?? 2025 Figure 5a??1: Gardasil/Gardasil 9 Market Value Analysis (Million US$), 2015 a?? 2019 Figure 5a??2: Gardasil/Gardasil 9 Market Value Forecast (Million US$), 2020 a?? 2025 Figure 5a??3: Cervarix Market Value Analysis (Million US$), 2015 a?? 2019 Figure 5a??4: Cervarix Market Value Forecast (Million US$), 2020 a?? 2025 Figure 5a??5: Provenge Market Value Analysis (Million US$), 2015 a?? 2019 Figure 5a??6: Provenge Market Value Forecast (Million US$), 2020 a?? 2025 Figure 5a??7: Imlygic Market Value Analysis (Million US$), 2016 a?? 2019 Figure 5a??8: Imlygic Market Value Forecast (Million US$), 2020 a?? 2025

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Medical Devices Reports

Portable Dialysis Devices Market Size, Share | Industry Analysis Report, 2026

According to credible estimates, the global portable dialysis devices market is expected to register substantial growth by the year 2026. Advancements in computer, miniaturization, and nanotechnology along with growing inclination towards portable me...

SPECT & SPECT-CT Market | Industry Analysis, Trends, and Forecast to 2025

SPECT and SPECT-CT market is likely to witness lucrative gains over 2020-2025 and reach a valuation of US $1810.9 million by the end of the forecast period. According to the estimates by reliable sources, the global SPECT and SPECT-CT market is anti...

Global Cardiovascular Catheter Stabilization Market Growth 2020-2025

According to this study, over the next five years the Cardiovascular Catheter Stabilization market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this r...

Global Medical Catheter Securement Devices Market Growth 2020-2025

According to this study, over the next five years the Medical Catheter Securement Devices market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this rep...

Global Femoral Cannula Market Growth 2020-2025

According to this study, over the next five years the Femoral Cannula market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the glo...

Other Reports by DPI Research

Cancer Vaccines Market, Pipeline Analysis Report 2020

a??Global Cancer Vaccines market size is expected to surpass US$ 8.5 Billion by 2025a?? Report Scope: a?? Detailed Insights of the Introduction to Cancer Vaccines and Mechanism of Cancer Vaccines a?? The Market Size of the Global Cancer Vaccines Mar...

Impact of COVID-19 Outbreak on Indian Outbound Travelers Traffic and Market Revenue to the GCC (United Arab Emirates (UAE), Saudi Arabia, Oman, Qatar, Kuwait, and Bahrain) Countries

It is forecasted that GCC countries will attract nearly 7.7 Million Indian travelers and generated more than US$ 12 billion market revenues by 2025. The objective of this market research report is to provide an overview of the development of the Ind...

Worldwide Diabetes Reusable Insulin Delivery Pen Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2026

Worldwide Diabetes Reusable Insulin Delivery Pen Market size is expected to touch US$ 6 billion by 2026. The following factors are likely to contribute to the growth of the diabetes reusable insulin delivery pen market during the forecast period: ‚...

Worldwide Diabetes Disposable Insulin Delivery Pen Market Prospect, Share, Development, Growth & Demand Forecast to 2026

Worldwide Diabetes Disposable Insulin Delivery Pen Market size is anticipated to exceed USD 14 billion by 2026. The objective of this market research report is to provide a comprehensive analysis of the fast-evolving, high-growth worldwide diabetes ...

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

‚ÄúTop 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies‚ÄĚ This report presents an in-depth assessme...

Publisher: DPI Research
Chat with us